Glycotest CEO Charles Swindell discusses the Company’s recently announced partnership with the University of Georgia Complex Carbohydrate Research Center and final steps toward market launch of the HCC Panel test for early-stage liver cancer with Proactive's Stephen Gunnion. Swindell described the importance of this collaboration for completing the HCC Panel commercial platform to make this potentially important liver cancer detection tool available to the patients at risk and the physicians who care for them. Watch at: https://lnkd.in/eVBqRJsQ.
Glycotest, Inc.
医疗和诊断实验室
Creating the New Clinical Standard for Early Diagnosis and Surveillance of Liver Cancer
关于我们
Glycotest is Creating the New Clinical Standard for Early Diagnosis and Surveillance of Liver Cancer
- 网站
-
https://www.glycotest.com/
Glycotest, Inc.的外部链接
- 所属行业
- 医疗和诊断实验室
- 规模
- 2-10 人
- 类型
- 私人持股
- 创立
- 2012
- 领域
- Liver Disease Diagnostics
地点
Glycotest, Inc.员工
动态
-
We are pleased to share the news that Glycotest, Inc. has entered into an agreement with the The University of Georgia Complex Carbohydrate Research Center (CCRC) to develop novel glycomic assays for its HCC Panel blood test. The agreement moves Glycotest towards commercializing its breakthrough platform, aimed at detecting early-stage liver cancer and giving patients a better chance at receiving curative treatment. Exciting times ahead! hashtag #LiverCancer hashtag #HealthcareInnovation hashtag #R&D hashtag #LifeSciences hashtag #Venturecapital